Lakefront Biotherapeutics (GLPGF) EPS (Basic) (2014 - 2026)
Lakefront Biotherapeutics' (GLPGF) quarterly EPS (Basic) came in at -$0.76 in Q2 2026, down 128.49% year-over-year from $2.67 in Q2 2025, and down 395.78% quarter-over-quarter from $0.26 in Q1 2026.
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) EPS (Basic) (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (GLPGF) has reported EPS (Basic) for 13 consecutive years, with -$0.76 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) fell 128.49% year-over-year to -$0.76 in Q2 2026; TTM through Jun 2026 was $5667.1, a 372.59% increase from a year earlier, with the FY2025 full-year figure at $5501.6, up 352.15% from the prior year.
- EPS (Basic) was -$0.76 for Q2 2026 at Lakefront Biotherapeutics, down from $0.26 in the prior quarter.
- Over five years, EPS (Basic) peaked at $5676.4 in Q4 2025 and troughed at -$8.84 in Q3 2025.
- A 5-year average of $573.78 and a median of $0.29 in 2022 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) surged 97187.36% in 2023 and slumped 447.3% in 2025, its largest moves.
- Over 5 years, EPS (Basic) stood at $3.55 in 2022, then surged by 97187.36% to $3456.3 in 2023, then slumped by 65.27% to $1200.5 in 2024, then soared by 372.83% to $5676.4 in 2025, then plunged by 100.01% to -$0.76 in 2026.
- The last three EPS (Basic) figures came in at -$0.76 (Q2 2026), $0.26 (Q1 2026), and $5676.4 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn | -0.40 |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn | -0.76 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.76 |
| Mar 31, 2026 | 0.26 |
| Dec 31, 2025 | 5,676.43 |
| Sep 30, 2025 | -8.84 |
| Jun 30, 2025 | 2.67 |
| Mar 31, 2025 | -2.45 |
| Dec 31, 2024 | 1,200.53 |
| Sep 30, 2024 | -1.62 |
| Jun 30, 2024 | 0.87 |
| Mar 31, 2024 | 1.49 |
| Dec 31, 2023 | 3,456.30 |
| Sep 30, 2023 | -0.54 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.38 |
| Dec 31, 2022 | 3.55 |
| Sep 30, 2022 | 0.33 |
| Jun 30, 2022 | -0.31 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | -0.96 |
| Sep 30, 2021 | -2.79 |